Starting with the first monoclonal antibody, muromonab-CD3, used for organ transplant rejection, these therapies have expanded into oncology, autoimmune diseases, and infectious diseases.

Used clinically since the 1920s, corticosteroids interrupt multiple steps in immune activation because of the ubiquitous expression of corticosteroid receptors. Corticosteroids inhibit antigen ...